ARCA biopharma (ABIO) SEC Filings & 10K Form → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free ABIO Stock Alerts $3.58 +0.10 (+2.87%) (As of 04/26/2024 ET) Add Compare Share Share SEC FilingsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Recent ARCA biopharma SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel DateFilerForm TypeView04/25/20243:27 PMARCA biopharma (Subject)Form 42504/23/20243:20 PMARCA biopharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 04/15/20244:29 PMAllostery Investments LP (Filed by)ARCA biopharma (Subject)Form SC 13G04/11/20248:51 AMARCA biopharma (Subject)JANUS HENDERSON GROUP PLC (Filed by)Form SC 13G04/09/20247:57 PMARCA biopharma (Subject)Avidity Partners Management LP (Filed by)Form SC 13G04/05/20246:38 PMARCA biopharma (Subject)Western Standard LLC (Filed by)Form SC 13G/A04/03/20246:31 AMARCA biopharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 04/03/20246:33 AMARCA biopharma (Subject)Form 42502/07/202412:08 PMARCA biopharma (Subject)BML Investment Partners, L.P. (Filed by)Form SC 13G/A02/01/20243:39 PMARCA biopharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 01/31/20245:39 PMARCA biopharma (Issuer)Ma-Weaver Jacob (Reporting)Form 4Statement of changes in beneficial ownership of securities 01/31/20243:25 PMARCA biopharma (Issuer)Woosley Raymond L. (Reporting)Form 4Statement of changes in beneficial ownership of securities 01/31/20243:25 PMARCA biopharma (Issuer)Grais Linda (Reporting)Form 4Statement of changes in beneficial ownership of securities 01/31/20243:25 PMARCA biopharma (Issuer)CONWAY ROBERT E (Reporting)Form 4Statement of changes in beneficial ownership of securities 01/31/20243:25 PMARCA biopharma (Issuer)Flynn James P (Reporting)Form 4Statement of changes in beneficial ownership of securities 01/31/20243:25 PMARCA biopharma (Issuer)MITCHELL DANIEL J (Reporting)Form 4Statement of changes in beneficial ownership of securities 01/31/20243:25 PMARCA biopharma (Issuer)Hove Anders D (Reporting)Form 4Statement of changes in beneficial ownership of securities 12/05/20233:25 PMARCA biopharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 12/04/20233:36 PMARCA biopharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 10/18/20233:15 PMARCA biopharma (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 10/18/20233:35 PMARCA biopharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 07/21/20233:35 PMARCA biopharma (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 07/21/20233:16 PMARCA biopharma (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) (Data available from 1/1/2016 forward) Related Companies and Tools Related Companies: Aspira Women's Health 10Q Form ImmuCell 10Q Form VolitionRx 10Q Form Alpha Teknova 10Q Form OncoCyte 10Q Form Cardio Diagnostics 10Q Form Trinity Biotech 10Q Form Achieve Life Sciences 10Q Form Eledon Pharmaceuticals 10Q Form Zepp Health 10Q Form SEC Filings Tools: Latest SEC FilingsInsider Trading Activity This page (NASDAQ:ABIO) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyProtect Your Bank Account Before It’s Too LateWeiss RatingsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThey say it’s ‘unstoppable’ – How I made 43,509% Investing DailyThe World's First "$20 Trillion Drug?"Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ARCA biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.